Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1964 1
1965 1
1969 1
1971 1
1973 2
1974 1
1976 2
1977 1
1978 3
1979 2
1982 1
1983 2
1984 1
1986 3
1987 3
1990 2
1991 2
1992 4
1993 2
1994 6
1995 6
1996 7
1997 5
1998 3
1999 9
2000 18
2001 17
2002 7
2003 19
2004 21
2005 23
2006 15
2007 9
2008 12
2009 20
2010 24
2011 13
2012 14
2013 27
2014 14
2015 8
2016 16
2017 17
2018 9
2019 10
2020 18
2021 14
2022 19
2023 13
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

431 results

Results by year

Filters applied: . Clear all
Page 1
AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.
Yadlapati R, Gyawali CP, Pandolfino JE; CGIT GERD Consensus Conference Participants. Yadlapati R, et al. Clin Gastroenterol Hepatol. 2022 May;20(5):984-994.e1. doi: 10.1016/j.cgh.2022.01.025. Epub 2022 Feb 2. Clin Gastroenterol Hepatol. 2022. PMID: 35123084 Free PMC article. Review.
BEST PRACTICE ADVICE 4: Clinicians should provide patients presenting with troublesome heartburn, regurgitation, and/or non-cardiac chest pain without alarm symptoms a 4- to 8-week trial of single-dose PPI therapy. ...BEST PRACTICE ADVICE 11: Clinicians should provi …
BEST PRACTICE ADVICE 4: Clinicians should provide patients presenting with troublesome heartburn, regurgitation, and/or non-cardiac c …
Gastroesophageal Reflux Disease: Pathophysiology, Diagnosis, and Treatment.
Chen J, Brady P. Chen J, et al. Gastroenterol Nurs. 2019 Jan/Feb;42(1):20-28. doi: 10.1097/SGA.0000000000000359. Gastroenterol Nurs. 2019. PMID: 30688703 Review.
Gastroesophageal reflux disease is one of the most frequent diseases encountered by primary care providers. The primary symptoms of GERD include heartburn, regurgitation, globus sensation, dysphagia, chest pain, and belching. ...
Gastroesophageal reflux disease is one of the most frequent diseases encountered by primary care providers. The primary symptoms of G …
Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021.
Iwakiri K, Fujiwara Y, Manabe N, Ihara E, Kuribayashi S, Akiyama J, Kondo T, Yamashita H, Ishimura N, Kitasako Y, Iijima K, Koike T, Omura N, Nomura T, Kawamura O, Ohara S, Ozawa S, Kinoshita Y, Mochida S, Enomoto N, Shimosegawa T, Koike K. Iwakiri K, et al. J Gastroenterol. 2022 Apr;57(4):267-285. doi: 10.1007/s00535-022-01861-z. Epub 2022 Feb 28. J Gastroenterol. 2022. PMID: 35226174 Free PMC article. Review.
Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
Weusten BLAM, Bisschops R, Dinis-Ribeiro M, di Pietro M, Pech O, Spaander MCW, Baldaque-Silva F, Barret M, Coron E, Fernández-Esparrach G, Fitzgerald RC, Jansen M, Jovani M, Marques-de-Sa I, Rattan A, Tan WK, Verheij EPD, Zellenrath PA, Triantafyllou K, Pouw RE. Weusten BLAM, et al. Endoscopy. 2023 Dec;55(12):1124-1146. doi: 10.1055/a-2176-2440. Epub 2023 Oct 9. Endoscopy. 2023. PMID: 37813356 Free article.
Weak recommendation, very low quality of evidence. MR4: ESGE recommends offering endoscopic eradication therapy using ablation to patients with BE and low grade dysplasia (LGD) on at least two separate endoscopies, both confirmed by a second experienced pathologist.Strong …
Weak recommendation, very low quality of evidence. MR4: ESGE recommends offering endoscopic eradication therapy using ablation to pat …
Evidence-based treatment recommendations for gastroesophageal reflux disease during pregnancy: A review.
Altuwaijri M. Altuwaijri M. Medicine (Baltimore). 2022 Sep 2;101(35):e30487. doi: 10.1097/MD.0000000000030487. Medicine (Baltimore). 2022. PMID: 36107559 Free PMC article. Review.
Gastroesophageal reflux disease (GERD) occurs in approximately two-thirds of all pregnancies. Around 25% of pregnant women experience heartburn daily. Symptomatic GERD usually presents in the first trimester and progresses throughout pregnancy. The treatment goal is to all …
Gastroesophageal reflux disease (GERD) occurs in approximately two-thirds of all pregnancies. Around 25% of pregnant women experience hea …
Eosinophilic esophagitis: Current concepts in diagnosis and treatment.
Gómez-Aldana A, Jaramillo-Santos M, Delgado A, Jaramillo C, Lúquez-Mindiola A. Gómez-Aldana A, et al. World J Gastroenterol. 2019 Aug 28;25(32):4598-4613. doi: 10.3748/wjg.v25.i32.4598. World J Gastroenterol. 2019. PMID: 31528089 Free PMC article. Review.
Eosinophilic esophagitis is an immune-allergic pathology of multifactorial etiology (genetic and environmental) that affects both pediatric and adult patients. Its symptoms, which include heartburn, regurgitation, and esophageal stenosis (with dysphagia being more frequent …
Eosinophilic esophagitis is an immune-allergic pathology of multifactorial etiology (genetic and environmental) that affects both pediatric …
Post-fundoplication symptoms and complications: Diagnostic approach and treatment.
Sobrino-Cossío S, Soto-Pérez JC, Coss-Adame E, Mateos-Pérez G, Teramoto Matsubara O, Tawil J, Vallejo-Soto M, Sáez-Ríos A, Vargas-Romero JA, Zárate-Guzmán AM, Galvis-García ES, Morales-Arámbula M, Quiroz-Castro O, Carrasco-Rojas A, Remes-Troche JM. Sobrino-Cossío S, et al. Rev Gastroenterol Mex. 2017 Jul-Sep;82(3):234-247. doi: 10.1016/j.rgmx.2016.08.005. Epub 2017 Jan 5. Rev Gastroenterol Mex. 2017. PMID: 28065591 Free article. Review. English, Spanish.
Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.
Farrell B, Pottie K, Thompson W, Boghossian T, Pizzola L, Rashid FJ, Rojas-Fernandez C, Walsh K, Welch V, Moayyedi P. Farrell B, et al. Can Fam Physician. 2017 May;63(5):354-364. Can Fam Physician. 2017. PMID: 28500192 Free PMC article.
OBJECTIVE: To develop an evidence-based guideline to help clinicians make decisions about when and how to safely taper or stop proton pump inhibitors (PPIs); to focus on the highest level of evidence available and seek input from primary care professionals in the guideline …
OBJECTIVE: To develop an evidence-based guideline to help clinicians make decisions about when and how to safely taper or stop proton pump i …
Diet and gastroesophageal reflux disease: role in pathogenesis and management.
Sethi S, Richter JE. Sethi S, et al. Curr Opin Gastroenterol. 2017 Mar;33(2):107-111. doi: 10.1097/MOG.0000000000000337. Curr Opin Gastroenterol. 2017. PMID: 28146448 Review.
PURPOSE OF REVIEW: Gastroesophageal reflux disease (GERD) is a common disease that presents with a variety of symptoms including heartburn and acid regurgitation. Although dietary modification is currently regarded as first-line therapy for the disease, the role of …
PURPOSE OF REVIEW: Gastroesophageal reflux disease (GERD) is a common disease that presents with a variety of symptoms including heartbur …
Antacids revisited: review on contemporary facts and relevance for self-management.
Garg V, Narang P, Taneja R. Garg V, et al. J Int Med Res. 2022 Mar;50(3):3000605221086457. doi: 10.1177/03000605221086457. J Int Med Res. 2022. PMID: 35343261 Free PMC article. Review.
Using supporting clinical evidence for different antacid ingredients, it also discusses the importance of antacids as OTC medicines and first-line therapies for heartburn, particularly in the era of the COVID-19 pandemic, in which reliance on self-care has in …
Using supporting clinical evidence for different antacid ingredients, it also discusses the importance of antacids as OTC medicines and firs …
431 results